ReWalk Robotics’ exo-suit designed for stroke rehabilitation.
ReWalk Robotics (NSDQ:RWLK) said it has applied to FDA for 510(k) clearance of its ReStore exoskeleton suit for gait training during stroke rehabilitation.
The Yokneam, Israel-based company designed its exo-suit to provide coordinated plantarflexion and dorsiflexion assistance to a patient’s foot and ankle. It recently won insurer reimbursement from Cigna and completed a clinical trial involving 44 patients at five rehabilitation centers in the U.S.
Get the full story on our sister site, Medical Design & Outsourcing.
The post ReWalk Robotics files for exoskeleton suit clearance appeared first on MassDevice.
from MassDevice http://bit.ly/2IBxlkD
Cap comentari:
Publica un comentari a l'entrada